// App-Quantinova.ai

2621 : Lower Apache II Score and Exchange Transfusions Predict Better Outcomes in the Intensive Care Unit for Patients with Sickle Cell Disease

Researchers

Presenter

  • Renee Cheng

Principal Investigators

  • Andrew Srisuwananukorn

  • Jin Han

  • Michel Gowhari

  • Franklin Njoku

  • Faiz Ahmed Hussain

  • Robert E. Molokie

  • Victor R. Gordeuk

  • Santosh L. Saraf

Medical Centers

  • Department of Medicine, University of Illinois at Chicago, Jesse Brown VA Medical Center, Chicago, IL

  • Mount Sinai Health Systems, New York, NY

  • Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL

  • Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL

  • Department of Psychology, University of Illinois at Chicago, Chicago, IL

  • Section of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL

  • Jesse Brown VA Medical Center, Chicago, IL

  • Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL

  • Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Deep vein thrombosis

  • Acute chest syndrome

  • Sickle cell anemia

  • Acute renal failure

  • Thalassemia

  • Venous thrombosis

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved